Publication | Closed Access

Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes

InflammationToll-like ReceptorsMetabolic SyndromeToll–like Receptor 4Genetic DeterminantCardiovascular DiseaseVascular InflammationDiabetesImmunologyHuman PolymorphismImmune-related Gene PolymorphismGene Asp299gly PolymorphismCardiovascular GeneticsVascular BiologyPublic HealthMedicineCardiovascular Disease PathogenesisEpidemiology